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Katz et al. have tried unsuccessfully to enhance primary antidinitrophenyl (DNP) 
responses to immunogenic DNP conjugates by the administration of allogeneic cells 
(1). Such conditions usually resulted in suppression, rather than enhancement, of the 
primary response (1). However, Osborne and Katz (2) showed that the poorly immuno- 
genic conjugate DNP-D-GL, when used in conjunction with an allogeneic stimulus, 
was  best able to  override the  need  for carrier-specific T  cells in  a  secondary anti- 
DNP  response.  In view  of  these  findings,  the  experiments described in  this paper 
were designed to examine if the allogeneic effect could elicit a  primary response to a 
hapten on a  nonimmunogenic carrier. 
Recently, 4-hydroxy-3-iodo-5-nitrophenylacetyl-conjugated  syngeneic mouse eryth- 
rocytes (NIP-MRBC)  were shown to be not only nonimmunogenic but also capable 
of rendering mice unresponsive at the level of the anti-NIP indirect plaque-forming 
cell (PFC) response when these mice were subsequently challenged with an immuno- 
genic NIP-conjugate  (3).  It was  reasoned  that  NIP-MRBC  might  be  the  type of 
hapten  conjugate capable of eliciting a  primary antihapten response as a  result of 
allogeneic stimulation. 
During preparation of this manuscript, Osborne and Katz (4) published data 
supporting the results presented in this paper. They have obtained a  primary, 
direct and indirect anti-DNP PFC response to DNP-D-GL in the presence of 
an ongoing graft-vs.-host (GVH) reaction but failed to demonstrate enhanced 
primary responses to the immunogens DNP-KLH  and DNP-OVA. 
Materials and Methods 
Anirnals.--Highly inbred CBA/J and (CBA/J)< C57B1/6)F1  hybrid mice were used (5). 
Antigens.--NIP  azide was prepared as described previously (3, 6). It was conjugated onto 
mouse  erythrocytes (MRBC)  or to chicken  erythrocytes (CRBC)  as described  previously 
(3).  Keyhole limpet hemocyanin (KLH) was  supplied from  Calbiochem,  San  Diego,  Calif. 
NIP-KLH was prepared by coupling  with azide (6).  Assuming  a  molecular weight of 106 
daltons for KLH, the conjugate with an average of 180 hapten groups per molecule was used, 
as determined spectrophotometrically (6). 
Cell Suspensions.--Spleen cell suspensions were prepared as described elsewhere (5). 
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Detection of Plaque-Formings  Cell (PFC).--Anti-NIP PFC  responses in spleen cell suspen- 
sions were detected according to the method of Cunningham  and Szenberg (7) and as described 
in ref. 3. 
Statistical Analyses.--Performed as previously described  (5). 
RESULTS 
Induction  of  a  Primary  Anti-NIP  PFC  Response  to  NIP-Ft.MRBC  by 
Allogeneic Cell Transfer.--Groups  of normal (CBA/J X  C57BI/6)F1 mice were 
injected intravenously with 5  X  107 normal parental CBA/] spleen cells and 
with  2  X  109  NIP-coupled  (CBA/J  X  C57BI/6)Ft  erythrocytes  (NIP- 
Ft. MRBC) on the same day, 2 days later, or 3 days later. A control group of 
normal (CBA/J X  C57B1/6)Ft mice were given 2 X  109 NIP-Ft. MRBC only. 
As  shown  in  Table I,  the control mice  (group  1)  which  did not  receive the 
TABLE  I 
Dependence of the Primary Response  to NIP-Ft" MRBC  on  the  Time of the Allogoneic Cell 
Transfer 
No. of  Days  Anti-NIP PFC per spleen at 7 days 
CBA/J  Primary challenge (cells)  between cell  after challenge 
Group spleen cells  transfer and 
transferred*  challenge  Direct  Indirect 
1  none  2 )< l0  g NIP-Ft.MRBC  0  0 
1  5 X  107  2 X  109 NIP-Ft.MRBC  0  4,000  (3,200-4,900)5  16,000  (13,000-19,500)§ 
3  5 X  107  2 )< 10  s NIP-Ft.MRBC  2  0  5,400  (4,900-6,000) 
4  5 X  107  2 X  109 NIP-FI.MRBC  3  0  1,000  (800-1,200) 
* For groups 2-4, normal (CBA/J X  C57B1/6)Ft mice were injected intravenously with 5  X  107 parental 
CBA/] cells at various times before intravenous challenge with the NIP-F1.MRBC; the mice in group 1, which 
received no allogeneic ceils, served as controls. 
~: Geometric mean, upper and lower limits of SE, 5-10 mice per group. 
§ P  values  between groups: Indirect PFC: 2 cf. 3, P  <  0.05; 2 cf. 4, P  <  0.05. 
allogeneic cells,  had no detectable anti-NIP PFC response when injected with 
2 X  10  9 NIP-F~. MRBC, a dose previously shown to be tolerogenic in mice (3). 
In  contrast,  all  mice  receiving  allogeneic  cells  developed  indirect  anti-NIP 
PFC responses after challenge with 2  X  10  9 NIP-Ft. MRBC. The magnitude 
of the response obtained was dependent upon the time interval between ad- 
ministration of allogeneic cells and challenge. Thus,  the group injected with 
NIP-Ft.MR~C  on the same day as cell transfer (group 2)  made the highest 
anti-NIP response, while an interval of 2 or 3 days between the administration 
of  the  allogeneic cells  and  challenge with  NIP-F1-MRBC  (groups  3  and 4, 
respectively) resulted in lower PFC responses measured 7 days later. A  small 
direct anti-NIP PFC response was also evident in group 2. 
Dependence of the Primary A nti-NIP PFC Response on the Dose of A llogeneic Cells.--Groups 
of normal  (CBA/J  X  C57B1/6)Ft  mice were injected  intravenously  with  varying  numbers 
of  normal  parental  CBA/J  spleen  cells  ranging  from  107-108  cells  per  recipient.  Normal 
(CBA/J  X  C57B1/6)F1  mice which received no allogeneic cells served as eontrols. All groups 
were injected  intravenously  with  2  )<  109 NIP-Ft'MRBC  shortly after cell  transfer.  Anti- 
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The results are presented in Table II. Allogeneic cell recipients manifested 
primary responses in terms of both direct and indirect anti-NIP PFC responses. 
The magnitude of the effect was clearly related to the number of allogeneic cells 
injected. The magnitude of the direct and indirect PFC responses on day 7 was 
highest either at a dose of 5  X  10  7 or 10  8 parental cells. However, it is possible 
that  peak  PFC  responses  with  other  doses of parental  cells may have  been 
reached at different times after the antigen injections. 
Dependence of the Primary Anti-NIP PFC Response  on  the Dose of NIP-Ft" MRBC.-- 
Groups of normal (CBA/J X  C57B1/6)F1 mice were either injected intravenously with 5 X 
107 normal parental CBA/J spleen  cells, or received no allogeneic cells as controls,  Imme- 
diately after transfer, mice from each group were injected intravenously with doses of NIP-Fv 
MRBC varying from 4 X  107 to 8 X  10 ~ cells. Direct and indirect anti-NIP PFC responses 
were determined 7 days later. 
The results are summarized in Table III. Control mice displayed no detect- 
TABLE II 
Dependence of the Primary Response to NIP-Fv MRBC on the Dose of Allogeneic Cells 
No. of 
CBA/J 
Group  spleen  Primary challenge (cells) 
cells 
transferred* 
Anti-NIP PFC per spleen at 7 days after challenge 
Direct  Indirect 
1  none  2 )<  109 NIP-FI.MRBC  0  0 
2  107  2 X  10  ° NIP-Ft.MRBC  1,700  (1,200-2,500)2  6,000  (3,100-12,000)§ 
3  2.5 )< 107  2 )<  109 NIP-F1.MRBC  1,600  (940-2,700)  10,000  (6,800-15,000) 
4  5 )< 107  2 X  109 NIP-F1.MRBC  13,000  (11,000-16,000)  50,000  (38,000-65,000) 
5  10  s  2 X  109 NIP-F1.MRBC  27,000  (20,000-36,000)  31,000  (27,000-35,000) 
* Groups of  (CBA/J  X  C57B1/6)F1  mice were injected  intravenously with varying numbers of parental 
CBA/J spleen cells; (CBA/J X  C57B1/6)F1 mice which received no allogeneic cells served as controls. All mice 
were injected intravenously with the NIP-FI-MRBC at the same time as the cell transfer. 
1: Geometric mean, upper and lower limits of SE, 5-10 mice per group. 
§ P  values between groups: Direct PFC: 2cf.4, P  <  0.05; 3cf.4, P  <  0.05 ; 5cf.4, P  <  0.05.  Indirect PFC: 2cf.4, 
P  <  0.05; 3cf.4, P  <: 0.05; 5cf.4, NS. 
TABLE III 
Effect of Varying  the Dose of NIP-Fx'MRBC on the Expression  of the Allogeneic  Effect 
No. of CBA/J  Dose of 
Group  spleen cells  NIP-FvMRBC 
transferred*  (cells) 
Anti-NIP PFC per spleen at 7 days after primary 
NIP-FvMRBC challenge 
Direct  Indirect 
1  5 X  107  4 X  107  130  (12-1,400)++  100  (10-1,200) 
2  5 X  107  4 )< l0 s  620  (160-2,300)§  1,400  (300-6,600) 
3  5 X  107  2 X  109  4,600  (2,3004,000)  36,000  (25,000-53,000) 
4  5 )< 107  8 )< 10  a  3,100  (1,900-5,000)  27,000  (23,000-31,000) 
* Groups of (CBA/J X  C57B1/6)F1 mice were injected intravenously with 5 X  107 parental CBA/J spleen 
cells. All mice were injected intravenously with varying doses of NIP-FI.MRBC  at the same time as the cell 
transfer. 
~; Geometric mean, upper and lower limits of SE, 5-10 mice per group. 
§ P  values between groups: Direct PFC: lcf.3, P  <  0.05; 2cf.3, NS; 4cf.3, NS. Indirect PFC: lcf.3, P  <  0.05; 
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able anti-NIP PFC at any dose of NIP-F1. MRBC employed. The highest doses 
were shown previously to be tolerogenic if the  indirect  anti-NIP response  to 
challenge with an immunogenic NIP-conjugate was measured  (3). In contrast, 
allogeneic cell recipients developed increasing primary anti-NIP responses with 
increasing doses of NIP-F1.MRBC up to 2-8  X  10  9 cells. 
Effect  of AUogeneic Cell Transfer  on Primary Anti-NIP PFC Responses to Different  NIP- 
Conjugates.--Groups  of normal  (CBA/J  X  C57B1/6)F1 mice were injected  intravenously 
with  5 X  107 normal parental  CBA/J spleen ceils, while control  (CBA/J  ×  C57B1/6)Ft 
mice received no allogeneic cell transfer. Immediately after cell transfer, both groups of mice 
were  injected  intraperitoneally  with  NIP-Fr MRBC  or  NIP-CBA. MRBC,  or  with  the 
immunogenic conjugates, NIP-CRBC or NIP-KLH. 
The  results  are  summarized  in  Table  IV.  Control  mice  (groups  1  and  3), 
TABLE IV 
Effect of Varying the Carrier on the Expression  of the Allogeneic Effect 
No. of CBA/J 
Group  spleen cells  Priming antigen 
transferred* 
Anti-NIP PFC per spleen at 7 days after challenge 
Direct  Indirect 
1  none  0  0 
2  5 X  107  2  X  109 NIP-FI.MRBC  110  (20  540)$  16,000  (14,000-19,000) 
3  none  2 X  109 NIP-CBA-MRBC  0  0 
4  5  X  107  3,000  (1,800-5,000)  13,000  (10,000-16,500) 
5  none  2  X  l0 g NIP-CRBC  0  2,200  (1,800-2,800)§ 
6  5  X  107  0  2,800  (2,000-3,900) 
7  none  250/xg NIP-KLH  240  (140-400)  1,800  (1,100  2,900) 
8  5 X  107  370  (220-630)  3,300  (3,000-3,500) 
* Groups of  (CBA/J  X  C57B1/6)Ft  mice were injected  intravenously with 5  X  107 parental  CBA/J  cells. 
Control  (CBA/J  X  C57B1/6)FI  mice received no allogeueic cells. All mice were injected intraperitoneally  with 
either NIP-Ft.MRBC, NIP-CBA.MRBC, NIP-CRBC, or fluid NIP-KLH immediately after cell transfer. 
Geometric mean, upper and lower limits of SE, 5-10 mice per group. 
§ P  values between groups: Direct PFC: 7cf.8, NS. Indirect PFC: 5cf.6, NS; 7cf.8, NS. 
which  received  no  allogeneic  cells  and  were  challenged  with  either 
NIP-F1. MRBC  or with NIP-CBA.MRBC, produced no detectable  anti-NIP 
PFC response while there was a  small response on challenge with NIP-CRBC 
and  with NIP-KLH  (groups 5  and  7).  The  administration  of allogeneic cells 
failed to increase the primary, indirect and indirect anti-NIP PFC response to 
NIP-CRBC and to NIP-KLH (groups 6 and 8). In marked contrast, the mice 
which  were injected  with  NIP-F1.MRBC or with NIP-CBA-MRBC  (groups 
2 and 4)  developed primary, direct and indirect  anti-NIP PFC responses.  No 
time-course for the PFC responses was carried out. 
DISCUSSION 
Data presented here shows that NIP-Ft.MRBC, which is normally able to 
induce a state of hapten-specific  tolerance (3), can be made to elicit a primary 
anti-NIP PFC response in the FI mouse provided an ongoing GVH reaction is 
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property of the parental or the syngeneic F1. MRBC carrier which distinguishes 
it from a  carrier such as CRBC or KLH. This difference in carriers possibly 
reflects the degree of T  cell recognition by either the F1 host or the parental 
donor and suggests that a "poor carrier," when attached to a hapten, can cause 
the induction of a primary response to the hapten in the presence of a  GVH 
reaction. The work of Osborne and Katz with DNP-D-GL (see IntrodUCtion 
and reference 4) and that of Byfield et al. with pneumococcal polysaccharide 
(Sill)  (quoted in reference 4), also demonstrate that the allogeneic effect can 
elicit primary antibody responses to substances for which little or no helper 
T  cell function exists. Other common features of these antigens are their high 
degree of persistance in vivo and their ability to induce tolerance (discussed, 
for example, in reference 8). 
The  relationship  of  the  production  of  the  antihapten  primary  response 
described in this paper to the response obtained with "immunogenic" hapten- 
protein conjugates is uncertain. The antihapten primary PFC  response prO- 
duced by the allogeneic effect presumably results from the stimulation of the 
T  cells in the parental spleen population by the F1 antigens with subsequent 
release of nonspecific factors capable of triggering B cells in the F1 host, either 
directly or indirectly. Experiments are in progress to determine the cell inter- 
actions involved, using an adoptive transfer system. 
The nature of the allogeneic effect is consistent with the mechanism of the 
classical T-B  collaboration being via "nonspecific factors" acting in conjunc- 
tion with antigen for the triggering of B cells, as discussed by Katz and Bena- 
cerraf (1, 9). 
SUMMARY 
A primary anti-NIP PFC response can be elicited by a  GVH reaction pro- 
vided certain structural requirements of the NIP-carrier are met. NIP-coated 
F1 erythrocytes and NIP-coated parental erythrocytes give rise to substantial 
anti-NIP PFC responses in F1 mice after the injection of parental spleens. These 
conjugates do not of themselves give rise to an anti-NIP PFC response and, 
in fact, normally give rise to NIP-specific tolerance. In contrast the GVH re- 
action is not able to enhance the primary anti-NIP PFC response to immuno- 
genic NIP-conjugates. 
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